Jasper Gross Profit from 2010 to 2024

JSPRW Stock

USD 0.20 0.01 5.26%

Jasper Therapeutics Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about -1.2 M in 2024. Gross Profit is the profit Jasper Therapeutics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

-1.1 M

Current Value

-1.2 M

Quarterly Volatility

488.8 K

Credit Downgrade

Yuan Drop

Covid

Check Jasper Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jasper Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Selling General Administrative of 11.2 M or Other Operating Expenses of 40 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.1. Jasper financial statements analysis is a perfect complement when working with Jasper Therapeutics Valuation or Volatility modules.

Check out the analysis of Jasper Therapeutics Correlation against competitors.

For more information on how to buy Jasper Stock please use our How to Invest in Jasper Therapeutics guide.

Latest Jasper Therapeutics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Jasper Therapeutics over the last few years. Gross profit is a required income statement account that reflects total revenue of Jasper Therapeutics minus its cost of goods sold. It is profit before Jasper Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Jasper Therapeutics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jasper Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Jasper Gross Profit Regression Statistics

	Arithmetic Mean	(291,893)
	Coefficient Of Variation	(167.45)
	Mean Deviation	397,310
	Median	(21,000)
	Standard Deviation	488,763
	Sample Variance	238.9B
	Range	1.3M
	R-Value	(0.76)
	Mean Square Error	110.1B
	R-Squared	0.57
	Significance	0
	Slope	(82,656)
	Total Sum of Squares	3.3T

Jasper Gross Profit History

	2024	-1.2 M
	2023	-1.1 M
	2022	-1.3 M
	2021	-566 K

Other Fundumenentals of Jasper Therapeutics

Gross Profit Margin

Jasper Therapeutics Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Capital Surpluse	Total Liab	Long Term Investments	Total Current Assets	Common Stock	Long Term Debt	Net Receivables	Long Term Debt Total	Net Invested Capital	Capital Stock	Net Working Capital	Current Deferred Revenue	Short Term Debt
Total Assets		0.83	-0.78	-0.96	-0.81	0.98	-0.53	0.77	0.29	0.7	1.0	-0.7	-0.53	-0.74	-0.53	0.97	0.58	1.0	-0.53	0.66
Total Stockholder Equity	0.83		-0.59	-0.9	-0.73	0.73	-0.68	0.38	-0.18	0.69	0.84	-0.39	-0.68	-0.7	-0.68	0.82	0.45	0.83	-0.68	0.66
Net Tangible Assets	-0.78	-0.59		0.8	0.96	-0.86	0.76	-0.89	-0.63	-0.77	-0.75	0.97	0.76	0.71	0.76	-0.85	-0.49	-0.82	0.76	-0.82
Net Debt	-0.96	-0.9	0.8		0.84	-0.93	0.72	-0.66	-0.23	-0.77	-0.96	0.68	0.72	0.81	0.72	-0.92	-0.48	-0.97	0.72	-0.66
Retained Earnings	-0.81	-0.73	0.96	0.84		-0.85	0.81	-0.81	-0.39	-0.86	-0.79	0.87	0.81	0.78	0.81	-0.89	-0.46	-0.83	0.81	-0.94
Accounts Payable	0.98	0.73	-0.86	-0.93	-0.85		-0.55	0.87	0.48	0.71	0.97	-0.82	-0.55	-0.75	-0.55	0.96	0.56	0.98	-0.55	0.67
Short Term Investments	-0.53	-0.68	0.76	0.72	0.81	-0.55		-0.39	-0.19	-0.85	-0.53	0.63	1.0	0.77	1.0	-0.57	-0.07	-0.58	1.0	-0.73
Capital Surpluse	0.77	0.38	-0.89	-0.66	-0.81	0.87	-0.39		0.74	0.56	0.74	-0.94	-0.39	-0.53	-0.39	0.84	0.6	0.78	-0.39	0.69
Total Liab	0.29	-0.18	-0.63	-0.23	-0.39	0.48	-0.19	0.74		0.2	0.26	-0.79	-0.19	-0.2	-0.19	0.33	0.25	0.34	-0.19	0.19
Long Term Investments	0.7	0.69	-0.77	-0.77	-0.86	0.71	-0.85	0.56	0.2		0.7	-0.66	-0.85	-0.97	-0.85	0.7	-0.01	0.7	-0.85	0.83
Total Current Assets	1.0	0.84	-0.75	-0.96	-0.79	0.97	-0.53	0.74	0.26	0.7		-0.66	-0.53	-0.75	-0.53	0.96	0.55	0.99	-0.53	0.63
Common Stock	-0.7	-0.39	0.97	0.68	0.87	-0.82	0.63	-0.94	-0.79	-0.66	-0.66		0.63	0.61	0.63	-0.77	-0.46	-0.73	0.63	-0.72
Long Term Debt	-0.53	-0.68	0.76	0.72	0.81	-0.55	1.0	-0.39	-0.19	-0.85	-0.53	0.63		0.77	1.0	-0.57	-0.07	-0.58	1.0	-0.73
Net Receivables	-0.74	-0.7	0.71	0.81	0.78	-0.75	0.77	-0.53	-0.2	-0.97	-0.75	0.61	0.77		0.77	-0.69	0.06	-0.74	0.77	-0.7
Long Term Debt Total	-0.53	-0.68	0.76	0.72	0.81	-0.55	1.0	-0.39	-0.19	-0.85	-0.53	0.63	1.0	0.77		-0.57	-0.07	-0.58	1.0	-0.73
Net Invested Capital	0.97	0.82	-0.85	-0.92	-0.89	0.96	-0.57	0.84	0.33	0.7	0.96	-0.77	-0.57	-0.69	-0.57		0.68	0.97	-0.57	0.78
Capital Stock	0.58	0.45	-0.49	-0.48	-0.46	0.56	-0.07	0.6	0.25	-0.01	0.55	-0.46	-0.07	0.06	-0.07	0.68		0.59	-0.07	0.36
Net Working Capital	1.0	0.83	-0.82	-0.97	-0.83	0.98	-0.58	0.78	0.34	0.7	0.99	-0.73	-0.58	-0.74	-0.58	0.97	0.59		-0.58	0.65
Current Deferred Revenue	-0.53	-0.68	0.76	0.72	0.81	-0.55	1.0	-0.39	-0.19	-0.85	-0.53	0.63	1.0	0.77	1.0	-0.57	-0.07	-0.58		-0.73
Short Term Debt	0.66	0.66	-0.82	-0.66	-0.94	0.67	-0.73	0.69	0.19	0.83	0.63	-0.72	-0.73	-0.7	-0.73	0.78	0.36	0.65	-0.73

Click cells to compare fundamentals

About Jasper Therapeutics Financial Statements

Jasper Therapeutics investors use historical fundamental indicators, such as Jasper Therapeutics' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jasper Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Gross Profit	-1.1 M	-1.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC